ANNUAL RATE OF FVC DECLINE IN PATIENTS WITH IPF TREATED WITH PIRFENIDONE: POOLED ANALYSIS (ENCORE)

被引：0
|
作者：
Noble, Paul W. [1 ]
Albera, Carlo [2 ]
Chou, Willis [3 ]
Costabel, Ulrich [4 ]
Day, Bann-Mo [3 ]
Glaspole, Ian [5 ,6 ]
Glassberg, Marilyn K. [7 ]
Lancaster, Lisa [8 ]
Lederer, David J. [9 ]
Nathan, Steven D. [10 ]
Pereira, Carlos A. [11 ]
Stauffer, John [3 ]
Swigris, Jeffrey J. [12 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Univ Turin, Turin, Italy
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Univ Duisburg Essen, Ruhrlandklin, Essen, Germany
[5] Alfred Hosp, Melbourne, Vic, Australia
[6] Monash Univ, Melbourne, Vic, Australia
[7] Univ Miami, Sch Med, Miami, FL USA
[8] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[9] Columbia Univ, Med Ctr, New York, NY USA
[10] Inova Fairfax Hosp, Falls Church, VA USA
[11] Univ Fed Sao Paulo, Paulista Sch Med, Sao Paulo, Brazil
[12] Natl Jewish Hlth, Denver, CO USA
来源：
RESPIROLOGY | 2017年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TO-119
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [1] Annual rate of FVC decline in patients with IPF treated with pirfenidone: Pooled analysis from 3 pivotal studies
    Noble, Paul
    Albera, Carlo
    Chou, Willis
    Costabel, Ulrich
    Day, Bannmo
    Glaspole, Ian
    Glassberg, Marilyn
    Lancaster, Lisa
    Lederer, David
    Nathan, Steven
    Pereira, Carlos
    Stauffer, John
    Swigris, Jeffrey
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [2] EFFECT OF CONTINUED PIRFENIDONE TREATMENT FOLLOWING ≥15% DECLINE IN 6MWD IN IPF PATIENTS-POOLED ANALYSIS (ENCORE)
    Nathan, Steven
    Albera, Carlo
    Costabel, Ulrich
    Glaspole, Ian
    Glassberg, Marilyn
    Lancaster, Lisa
    Lederer, David
    Pereira, Carlos
    Swigris, Jeffrey
    Pavlov, Andrey
    Stauffer, John
    Day, Bann-Mo
    Chou, Willis
    Wells, Athol
    RESPIROLOGY, 2017, 22 : 79 - 79
  • [3] ANNUAL RATE OF FVC DECLINE IN VARIOUS PATIENT SUB-GROUPS WITH IDIOPATHIC PULMONARY FIBROSIS TREATED WITH PIRFENIDONE: POOLED ANALYSIS FROM 3 PIVOTAL STUDIES
    Noble, P. W.
    Albera, C.
    Chou, W.
    Costabel, U.
    Day, B.
    Glaspole, I.
    Glassberg, M. K.
    Lancaster, L.
    Lederer, D. J.
    Nathan, S. D.
    Pereira, C. A.
    Stauffer, J.
    Swigris, J. J.
    THORAX, 2016, 71 : A57 - A57
  • [4] Functional decline over time in patients with IPF treated with pirfenidone: the PROOF registry
    Wuyts, Wim
    Dahlqvist, Caroline
    Slabbynck, Hans
    Schlesser, Marc
    Gusbin, Natacha
    Compere, Christophe
    Maddens, Sofie
    Kirchgaessler, Klaus-Uwe
    Bartley, Karen
    Bondue, Benjamin
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [5] FVC DECLINE OVER 1 YEAR PREDICTS MORTALITY BUT NOT SUBSEQUENT FVC DECLINE IN PATIENTS WITH IPF
    Richeldi, L.
    Kolb, M.
    Azuma, A.
    Stansen, W.
    Quaresma, M.
    Stowasser, S.
    Crestani, B.
    THORAX, 2017, 72 : A252 - +
  • [6] FVC decline over 1 year predicts mortality but not subsequent FVC decline in patients with IPF
    Richeldi, Luca
    Kolb, Martin
    Azuma, Arata
    Stansen, Wibke
    Quaresma, Manuel
    Stowasser, Susanne
    Crestani, Bruno
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [7] 'Real World' Therapeutic Approach and Associations with FVC Decline in IPF Patients Treated with Antifibrotics
    Adams, C.
    Shapera, S.
    Ryerson, C. J.
    Wilcox, P.
    To, T. M.
    Sadatsafavi, M.
    Morisset, J.
    Marcoux, V.
    Manganas, H.
    Kolb, M. R.
    Khalil, N.
    Johannson, K. A.
    Hambly, N.
    Halayko, A. J.
    Gershon, A. S.
    Fell, C. D.
    Cox, G. P.
    Assayag, D.
    Garlick, K.
    Fisher, J. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [8] Association between weight loss and decline in FVC in patients with IPF
    Crestani, Bruno
    Cottin, Vincent
    Thibault, Ronan
    Lederlin, Mathieu
    Vernhet, Laurent
    Stansen, Wibke
    Quaresma, Manuel
    Jouneau, Stephane
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [9] Association between weight loss and decline in FVC in patients with IPF
    Costabel, U.
    Crestani, B.
    Cottin, V
    Thibault, R.
    Lederlin, M.
    Vernhet, L.
    Stansen, W.
    Quaresma, M.
    Jouneau, S.
    PNEUMOLOGIE, 2020, 74 : S100 - S101
  • [10] Real World experiences: Pirfenidone is well tolerated and reduces decline in FVC and TLCO at 9 months in IPF
    Chaudhuri, Nazia
    Duck, Annette
    Holme, Jayne
    Frank, Rebecca
    Leonard, Colm
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
12345